Tumor Biology

, Volume 36, Issue 11, pp 8735–8745 | Cite as

Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma

  • Yayun Wang
  • Li Liang
  • Jianguo Zhang
  • Mei Li
  • Junya Zhu
  • Chen Gong
  • Linlin Yang
  • Jia Zhu
  • Lingling Chen
  • Runzhou Ni
Research Article


Sam68 (Src-associated in mitosis of 68 kD) is a KH domain RNA-binding protein. The expression of Sam68 was correlated with kinds of tumors. Yet, the expression mechanisms and physiological significance of Sam68 in ESCC remains unclear. In this study, we clarified a potential role of Sam68 in the treatment of ESCC. Western blot and immunohistochemistry (IHC) analysis revealed that the protein level of Sam68 was higher in ESCC tumor tissues and cell lines. In addition, IHC stain revealed that Sam68 was positively correlated with clinical pathologic variables such as tumor grade and tumor invasion. In addition, Sam68 could be an independent prognostic indicator for patients’ overall survival. In vitro studies such as starvation and refeeding assay along with Sam68-shRNA transfection assay demonstrated that Sam68 expression promoted proliferation of ESCC cells. And Sam68 downregulation caused decreased rate of cell growth and colony formation. Reasons are associated with growth arrest of cell cycle at G1/S phase. Moreover, our results clarified that Sam68 could promote ESCC cell proliferation via the activation of Akt/GSK-3β pathway. This research indicated that Sam68 might accelerate the cell cycle progression and be considered as a new therapy target in ESCC.


Esophageal squamous cell carcinoma (ESCC) Sam68 Proliferation Prognosis 



This work was supported by the Natural Science Foundation of China (No. 81272708).

Conflicts of interest

All the authors declare no conflict of interest.


  1. 1.
    Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:2137–50.CrossRefGoogle Scholar
  2. 2.
    Okines A, Cunningham D, Chau I. Targeting the human egfr family in esophagogastric cancer. Nat Rev Clin Oncol. 2011;8:492–503.CrossRefPubMedGoogle Scholar
  3. 3.
    Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509:91–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Bielli P, Busa R, Paronetto MP, Sette C. The rna-binding protein sam68 is a multifunctional player in human cancer. Endocr Relat Cancer. 2011;18:R91–102.CrossRefPubMedGoogle Scholar
  5. 5.
    Johnson DL, Johnson SA. Cell biology. Rna metabolism and oncogenesis. Science. 2008;320:461–2.CrossRefPubMedGoogle Scholar
  6. 6.
    Modem S, Chinnakannu K, Bai U, Reddy GP, Reddy TR. Hsp22 (hspb8/h11) knockdown induces sam68 expression and stimulates proliferation of glioblastoma cells. J Cell Physiol. 2011;226:2747–51.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Taylor SJ, Resnick RJ, Shalloway D. Sam68 exerts separable effects on cell cycle progression and apoptosis. BMC Cell Biol. 2004;5:5.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Song L, Wang L, Li Y, Xiong H, Wu J, Li J, et al. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells. J Pathol. 2010;222:227–37.CrossRefPubMedGoogle Scholar
  9. 9.
    Busa R, Paronetto MP, Farini D, Pierantozzi E, Botti F, Angelini DF, et al. The rna-binding protein sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene. 2007;26:4372–82.CrossRefPubMedGoogle Scholar
  10. 10.
    Li Z, Yu CP, Zhong Y, Liu TJ, Huang QD, Zhao XH, et al. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2012;23:638–46.CrossRefGoogle Scholar
  11. 11.
    Li QH, Haga I, Shimizu T, Itoh M, Kurosaki T, Fujisawa J. Retardation of the g2-m phase progression on gene disruption of rna binding protein sam68 in the dt40 cell line. FEBS Lett. 2002;525:145–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Chawla G, Lin CH, Han A, Shiue L, Ares Jr M, Black DL. Sam68 regulates a set of alternatively spliced exons during neurogenesis. Mol Cell Biol. 2009;29:201–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Paronetto MP, Cappellari M, Busa R, Pedrotti S, Vitali R, Comstock C, et al. Alternative splicing of the cyclin d1 proto-oncogene is regulated by the rna-binding protein sam68. Cancer Res. 2010;70:229–39.CrossRefPubMedGoogle Scholar
  14. 14.
    Lukong KE, Richard S. Targeting the rna-binding protein sam68 as a treatment for cancer? Future Oncol. 2007;3:539–44.CrossRefPubMedGoogle Scholar
  15. 15.
    Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan Q, et al. Overexpression of forkhead box j2 can decrease the migration of breast cancer cells. J Cell Biochem. 2012;113:2729–37.CrossRefPubMedGoogle Scholar
  16. 16.
    Wan C, Hou S, Ni R, Lv L, Ding Z, Huang X, et al. Mif4g domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing cdk2-dependent p27 stability. Oncogene. 2015;34:237–45.CrossRefPubMedGoogle Scholar
  17. 17.
    Malumbres M, Barbacid M. Cell cycle, cdks and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153–66.CrossRefPubMedGoogle Scholar
  18. 18.
    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.CrossRefPubMedGoogle Scholar
  19. 19.
    Kobayashi M, Kato K, Iwama H, Fujihara S, Nishiyama N, Mimura S, et al. Antitumor effect of metformin in esophageal cancer: in vitro study. Int J Oncol. 2013;42:517–24.PubMedGoogle Scholar
  20. 20.
    Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. Eurocare-3: Survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2003;14 Suppl 5:v61–118.CrossRefGoogle Scholar
  21. 21.
    Chen T, Boisvert FM, Bazett-Jones DP, Richard S. A role for the gsg domain in localizing sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell. 1999;10:3015–33.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Paronetto MP, Zalfa F, Botti F, Geremia R, Bagni C, Sette C. The nuclear rna-binding protein sam68 translocates to the cytoplasm and associates with the polysomes in mouse spermatocytes. Mol Biol Cell. 2006;17:14–24.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Sharma S, Tammela J, Wang X, Arnouk H, Driscoll D, Mhawech-Fauceglia P, et al. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin Cancer Res Off J Am Assoc Cancer Res. 2007;13:5889–96.CrossRefGoogle Scholar
  24. 24.
    Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY, et al. Regulation of gene expression by the rna-binding protein sam68 in cancer. Biochem Soc Trans. 2008;36:505–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Lukong KE, Richard S. Sam68, the kh domain-containing superstar. Biochim Biophys Acta. 2003;1653:73–86.PubMedGoogle Scholar
  26. 26.
    Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem. 2005;280:38639–47.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Yayun Wang
    • 1
  • Li Liang
    • 3
  • Jianguo Zhang
    • 2
  • Mei Li
    • 3
  • Junya Zhu
    • 1
  • Chen Gong
    • 1
  • Linlin Yang
    • 4
  • Jia Zhu
    • 4
  • Lingling Chen
    • 1
  • Runzhou Ni
    • 1
  1. 1.Department of GastroenterologyAffiliated Hospital of Nantong UniversityNantongChina
  2. 2.Department of PathologyAffiliated Hospital of Nantong UniversityNantongChina
  3. 3.Department of Medical OncologyAffiliated Hospital of Nantong UniversityNantongChina
  4. 4.Department of OncologyAffiliated Cancer Hospital of Nantong UniversityNantongChina

Personalised recommendations